Altered biochemical parameters in the saliva of patients with breast cancer

Tohoku Journal of Experimental Medicine

Volumn 214, Issue 2, 2008, Pages 89-96

  Emekli Alurfan, Ebru ^a   Demir, Gokhan ^b   Kasikci, Emel ^a   Tunali Akbay, Tugba ^a   Pisiriciler, Rabia ^a   Caliskan, Esin ^a   Yarat, Aysen ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Breast cancer; Lipid peroxidation; Protein; Saliva; Tissue factor

Indexed keywords

ANASTROZOLE; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; SALIVA PROTEIN; THROMBOPLASTIN; TRASTUZUMAB; ZOLEDRONIC ACID;

ADULT; ARTICLE; BIOCHEMICAL COMPOSITION; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; LEUKOCYTE; LIPID PEROXIDATION; PH MEASUREMENT; POLYACRYLAMIDE GEL ELECTROPHORESIS; RISK FACTOR; SALIVA ANALYSIS; SALIVATION;

AZURE STAINS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ELECTROPHORESIS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LIPID PEROXIDATION; MIDDLE AGED; SALIVA; SALIVATION; STATISTICS, NONPARAMETRIC; THROMBOPLASTIN;

EID: 41949127889     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.214.89     Document Type: Article

References (41)

1. Alturfan, A.A., Alturfan, E.E., Dariyerli, N., Zengin, E., Aytac, E., Yigit, G. & Kokoglu, E. (2006) Investigation of tissue factor and other hemostatic profiles in experimental hypothyroidism. Endocrine, 30, 63-67.
2. Arana, C., Cutando, A., Ferrera, M.J., Gómez-Moreno, G., Worf, C.V., Bolaños, M.J., Escames, G. & Acuña-Castroviejo, D. (2006) Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J. Oral Pathol. Med., 35, 554.
3. Auger, M.J. & Mackie, M.J. (1988) Effects of tamoxifen on blood coagulation. Cancer, 1, 1316-1319.
4. Atay, Z. & Topalidis, T. (1994) Cytodiagnostik der Serösen Höhlen. Atlas and Lehrbuch. Wolfgang Pabst verlag, Hannover.
5. Bellis, C. & Scott, F.H. (1933) Saliva and blood coagulation. Proc. Soc. Exp. Biol. Med., 30, 1373.
6. Bigler, L.R., Streckfus, C.F., Copeland, L., Burns, R., Dai, X., Kuhn, M., Martin, P. & Bigler, S.A.J. (2002) The potential use of saliva to detect recurrence of disease in women with breast carcinoma. Oral Pathol. Med., 31, 421-431.
7. Dawes, C. (1996) Factors influencing salivary flow rate and composition. In: Edgar WM, O'mualle DM (eds) Saliva and oral health. Thanet Press Limited, Margate, UK, pp. 27-41.
8. Doku, H.C. & Taylor, R.G. (1962) Thromboplastin generation by saliva. Oral Surg. Oral Med. Oral Pathol., 15, 1295-1301.
9. Emekli-Alturfan, E., Kasikci, E. & Yarat, A. (2007) Tissue factor activities of streptozotocin induced diabetic rat tissues and the effect of peanut consumption. Diabetes Metab. Res. Rev., 23, 653-658.
10. Epstein, J.B., Robertson, M., Emerton, S., Phillips, N. & Stevenson-Moore, P. (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck, 23, 389-398.
11. Ersner, M.S., Myers, D. & Ersner, W. (1934) A clinical and experimental study of the action of saliva on blood coagulation and wound healing in surgery of the oral cavity and throat. Ann. Oral. Rhinol. Laryngol., 43, 114.
12. Fareed, J., Callas, D.D., Hoppensteadt, D. & Bermes, E.W. Jr. (1995) Tissue factor antigen levels in various biological fluids. Blood Coag. Fibrinol., 6, 32-36.
13. Gago-Dominguez, M., Castelao, E., Pike, M.C., Sevanian, A. & Robert, W. (2005) Role of Lipid Peroxidation in the Epidemiology and Prevention of Breast Cancer. Cancer Epidemiol. Biomarkers Prev., 14, 2829-2839.
14. Glazko, A.J. & Greenberg, D.M. (1939) The mechanism of the action of saliva in blood coagulation. Am. J. Physiol., 125, 108.
15. Hale, L.P. (2002) Zinc-α2-glycoprotein Regulates Melanin Production by Normal and Malignant Melanocytes. J. Invest. Dermat., 119, 464-470.
16. Hannig, M., Dounis, E., Henning, T., Apitz, N. & Stößer, L. (2006) Does irradiation affect the protein composition of saliva? Journal Clinical Oral Investigations, 10, 61-65.
17. Ingram, G.I.C. & Hills, M. (1976) Reference method for the one stage prothrombin time test on human blood. Thromb. Haemostas., 36, 237-238.
18. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
19. Lopes-Bezerra, L.M. & Filler, S.G. (2003) Endothelial cells, tissue factor and infectious diseases. Braz. J. Med. Biol. Res., 36, 987-991.
20. Lowry, O.H., Rosebrough, W.I., Fort, A.L. & Randal, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193, 265-275.
21. Makkonen, T.A., Tenovuo, J., Vilja, P. & Heimdahl, A. (1986) Changes in the protein composition of whole saliva during radiotherapy in patients with oral or pharyngeal cancer. Oral Surg. Oral Med. Oral Pathol., 62, 270-275.
22. Mandel, I.D. (1987) The function of saliva. J. Dent. Res., 66, 623-627.
23. Marutsuka, K., Hatakeyama, K., Yamashita, A. & Asada, Y. (2005) Role of thrombogenic factors in the development of atherosclerosis. J. Atheroscler. Thromb., 12, 1-8.
24. Miller, C.S., Epstein, J.B., Hall, E.H. & Sirois, D. (2001) Changing oral care needs in the United States: the continuing need for oral medicine. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 91, 34-44.
25. National Institute of Health Consensus Development Conference on Oral Complications of Cancer Therapies (1990) Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17-19, 1989. NCI Monogr; 9, 1-184.
26. Nemerson, Y. (1995) Tissue factor: then and now. Thromb. Haemost., 74, 180-184.
27. Noun-Eldin, F. & Wilkinson, J.F. (1957) The blood clotting factors in human saliva. J. Physiol., 136, 324.
28. Price, G.C., Thompson, S.A. & Kam, P.C.A. (2004) Tissue factor and tissue factor pathway inhibitor. Anaesthesia, 59, 483-492.
29. Rauch, U. & Nemerson, Y. (2000) Circulating tissue factor and thrombosis. Curr. Opin. Hematol., 7, 273-277.
30. Salganik, R.I. (2001) The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J. Am. Coll. Nutr., 20, 473-475.
31. Schenkels, L.C., Veerman, E.C. & Nieuw Amerongen, A.V. (1995) Biochemical composition of human saliva in relation to other mucosal fluids. Crit. Rev. Oral Biol. Med., 6, 161-175.
32. Sodergren, E. (2000) Lipid peroxidation in vivo. Evaluation and application of methods for measurement. Uppsala: Acta Universitatis Upsaliensis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, pp. 949.
33. Sonis, S.T., Oster, G., Fuchs, H., Bellm, L., Bradford, W.Z., Edelsberg, J., Hayden, V., Eilers, J., Epstein, J.B., LeVeque, F.G., Miller, C., Peterson, D.E., Schubert, M.M., Spijkervet, F.K. & Horowitz, M. (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J. Clin. Oncol., 19, 2201-2205.
34. Streckfus, C. & Bigler, L. (2005) The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv. Dent. Res., 18, 17-24.
35. Ueno, T., Toi, M., Koike, M., Nakamura, S. & Tominaga, T. (2000) Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br. J. Cancer, 83, 164-170.
36. Versteeg, H.H., Spek, C.A., Peppelenbosch, M.P. & Richel, D.J. (2004) Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol. Med., 10, 6-11.
37. Walsh, J., Wheeler, H.R. & Geczy, C.L. (1992) Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br. J. Haematol., 81, 480-488.
38. WHO (2006) Cancer. Fact sheet No. 297.
39. Yagi, K. (1984) Assay for blood plasma or serum. Methods Enzymol., 105, 328-337.
40. Yarat, A., Tunali, T., Pisiriciler, R., Akyuz, S., Ipbuker, A. & Emekli, N. (2004) Salivary thromboplastic activity in diabetics and healthy controls. Clin. Oral Invest., 8, 36-39.
41. Zacharski, L.R. & Rosenstein, R. (1979) Reduction of salivary tissue factor (Thromboplastin) activity by warfarin therapy. Blood, 53, 366-374.